The regional distribution of somatostatin and neuropeptide Y in control and Alzheimer's disease striatum

[1]  J. B. Martin,et al.  Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: A combined immunocytochemical and enzyme histochemical study , 1987, Neuroscience.

[2]  Joseph B. Martin,et al.  Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease , 1986, Annals of neurology.

[3]  Joseph B. Martin,et al.  A comparison of regional somatostatin and neuropeptide Y distribution in rat striatum and brain , 1986, Brain Research.

[4]  A. Parent,et al.  Neuropeptide Y-immunoreactive neurons in the striatum of cat and monkey: Morphological characteristics, intrinsic organization and co-localization with somatostatin , 1986, Brain Research.

[5]  A. Graybiel,et al.  Striatal neurons expressing somatostatin-like immunoreactivity: Evidence for a peptidergic interneuronal system in the cat , 1986, Neuroscience.

[6]  Joseph B. Martin,et al.  An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditions , 1986, Neuroscience Letters.

[7]  P. Emson,et al.  Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease , 1985, Brain Research.

[8]  V. B. Domesick,et al.  Effects of lesions in the amygdala and periventricular hypothalamus on striatal somatostatin-like immunoreactivity , 1985, Brain Research.

[9]  I. Kanazawa,et al.  Tridimensional distribution of markers of neurotransmitters within the “accumbens area” of normal human brains , 1984, Neuroscience.

[10]  T. Hökfelt,et al.  Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat , 1984, Neuroscience.

[11]  I. Ferrier,et al.  Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia , 1984, Journal of the Neurological Sciences.

[12]  Joseph B. Martin,et al.  Somatostatin is increased in the nucleus accumbens in Huntington's disease , 1984, Neurology.

[13]  I. Ferrier,et al.  Neuropeptides in Alzheimer type dementia , 1983, Journal of the Neurological Sciences.

[14]  T. Hökfelt,et al.  NADPH‐diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin‐ and avian pancreatic polypeptide (APP)‐like immunoreactivities , 1983, The Journal of comparative neurology.

[15]  P. Somogyi,et al.  Fine structural studies on a type of somatostatin‐immurioreactive neuron and its synaptic connections in the rat neostriatum: A correlated light and electron microscopic study , 1983, The Journal of comparative neurology.

[16]  L. Swanson,et al.  Neural projections from nucleus accumbens to globus pallidus, substantia innominata, and lateral preoptic-lateral hypothalamic area: an anatomical and electrophysiological investigation in the rat , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  N. Aronin,et al.  Ultrastructural features of immunoreactive somatostatin neurons in the rat caudate nucleus , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  E. Bird,et al.  Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain , 1982, Annals of neurology.

[19]  L. Iversen,et al.  Regional Distribution of Neurotensin in Human Brain , 1982, Journal of neurochemistry.

[20]  P. Davies,et al.  Anterior to posterior variations in the concentration of somatostatin-like immunoreactivity in human basal ganglia , 1981, Brain Research Bulletin.

[21]  L. Iversen,et al.  Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type , 1980, Neuroscience Letters.

[22]  J. Rossum,et al.  Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens , 1973, The Journal of pharmacy and pharmacology.